2010-2017年疫苗不良事件报告系统中灭活流感疫苗接种后非典型肩痛与功能障碍的报告
研究检索2010年7月至2017年6月疫苗不良事件报告系统(VAERS)中灭活流感疫苗(IIV)接种后非典型肩痛与功能障碍的报告,共纳入1220份符合病例定义的报告(占所有IIV报告的2.0%)。中位年龄52岁,82.6%为女性,86.6%的报告在提交时症状未缓解。作者认为此类报告不常见且各流感季稳定,接种操作不当可能是可预防的因素。
要点
- 共1220份报告符合病例定义,占所有IIV报告的2.0%,各流感季范围1.5%-2.5%。
- 中位年龄52岁(范围16-94),82.6%为女性。
- 86.6%的报告在提交时症状和体征尚未缓解。
核心结论
- 考虑到IIV的使用量,接种后非典型肩痛与功能障碍的报告不常见,且在各流感季保持稳定。
- 具体病因未知,但接种操作不当(可预防)可能是因素之一。
- 预防策略包括教育、培训以及遵循疫苗接种的最佳实践。
研究设计与样本
- 对疫苗不良事件报告系统(VAERS)2010年7月至2017年6月的报告进行描述性分析。
- 病例定义:接种IIV后疼痛在48小时内开始且体征和症状持续超过7天,以区别于自限性局部反应。
- 共识别1220份符合病例定义的报告。
主要发现
- 1220份报告占所有IIV报告的2.0%,各流感季范围1.5%-2.5%。
- 中位年龄52岁(范围16-94),82.6%为女性。
- 常见报告:肩痛44.1%、注射肢体活动度下降40.8%、关节活动范围下降21.2%、肩袖综合征9.2%、滑囊炎9.0%。
- 86.6%的报告在提交时症状和体征尚未缓解。
- 在包含提示 contributing factors 描述的报告(n=266)中,81.2%提到疫苗接种部位「过高」。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vaccines administered into or too close to underlying joint structures have the potential to cause shoulder injuries. Limited data exist on the epidemiology of such events. OBJECTIVE: To describe case reports of atypical shoulder pain and dysfunction following injection of inactivated influenza vaccine (IIV). METHODS: We searched the Vaccine Adverse Event Reporting System (VAERS) database from July 2010 to June 2017 for reports of atypical shoulder pain and dysfunction following IIV. When identifying reports, we made no assumptions about true incident injury or causality with respect to vaccination. Pain had to begin <48 h after vaccination and signs and symptoms had to continue for >7 days to differentiate from self-limited local reactions. We conducted descriptive analysis. RESULTS: We identified 1220 reports that met our case definition (2.0% of all IIV reports, range 1.5%-2.5% across influenza seasons). Median age was 52 years (range 16-94) and most patients (82.6%) were female. Shoulder pain (44.1%), injected limb mobility decreased (40.8%), joint range of motion decreased (21.2%), rotator cuff syndrome (9.2%), and bursitis (9.0%) were frequently reported. In 86.6% of reports, signs and symptoms had not resolved by the time of report submission. In reports that included descriptions suggesting contributing factors (n = 266), vaccination given "too high" on the arm was cited in 81.2%. Nearly half (n = 605, 49.6%) of reports described a healthcare provider evaluation. Treatments included non-narcotic analgesics, physical therapy, and corticosteroid injection. Vaccinations were most commonly administered in a pharmacy or retail store (41.0%) or doctor's office or hospital (31.6%). CONCLUSIONS: Reports of atypical shoulder pain and dysfunction following IIV were uncommon, considering the amount of IIV use, and stable across influenza seasons. While specific etiology of cases is unknown, improperly administered vaccine, which is preventable, might be a factor. Prevention strategies include education, training, and adherence to best practices for vaccine administration.
引用
- Hibbs BF, Ng CS, Museru O, et al. Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017. Vaccine. 2019. PMID: 31784231. doi:10.1016/j.vaccine.2019.11.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。